Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazax in Allergic Grass Pollen Rhinitis (GRAAL)
NCT01433510Phase 4Completed
- Sponsor
- ALK-Abelló
- Start
- Nov 2007
- Primary completion
- Oct 2010
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of grass-pollen extract in allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Nov 2007; status: completed.
02
Drugs
grass-pollen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT01433510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433510.